AVLN

28.6900.03%
JC

Jill Carroll

Independent Director

Ms. Jill Carroll, M.S., serves as Operating Partner at SR One Capital Management, LP since 2026. At the firm, she also served as Partner until 2026, as Principal and as Senior Associate from September 2011. She joined SR One Capital Management in September 2011. Ms. Carroll serves as an Independent Director at Avalyn Pharma Inc. since September 27, 2023. She was Independent Director at Arcellx, Inc. since September 2017 until April 28, 2026. She served as an Independent Director at Odyssey Therapeutics, Inc. since August 2021 until May 07, 2026. She also serves as Director at Poplar Therapeutics, Inc., Pandion Operations, Inc., HotSpot Therapeutics, Inc., AirNexis Therapeutics and Ancora Biotech. Her prior roles include serving as Independent Director at Pandion Therapeutics, Inc. from July 2019 to 2021. She served as Director at Second Genome, Inc. since July 13, 2016, as Director at Arch Oncology, Inc. since August 16, 2016 and as Director at Tioma Therapeutics, Inc. since August 16, 2016. She also served as Director at Nkarta, Inc., Gotham Therapeutics, Alios and at Beacon Therapeutics (USA), Inc. from April 2013 to July 31, 2014. Previously, Ms. Carroll served as Vice President of Strategic Corporate Development at Limerick BioPharma, Inc. from August 2010 to August 2011. She was Senior Director, Corporate Development at Dynavax Technologies Corporation from May 2004 to August 2010. She served as a biopharmaceutical industry consultant for Clearview Projects, Inc. from October 2001 to May 2004 and for Mercer Management Consulting from March 1999 to July 2001. At SR One, she is managing key investments including Arcellx, Odyssey and Avalyn and devotes significant time to developing the firm’s talented junior investing team. She has a background in biotech partnering and corporate development and while at Dynavax Technologies Corporation, she completed multiple pharma partnerships and substantial private and public financings. Ms. Carroll received her M.S. in Cellular Biology, Biochemistry & Molecular Biology from Johns Hopkins University from 1997 to 1999 and her B.S. in Chemistry from Duke University from 1993 to 1997.

Positions